Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Astrazeneca, Bayer, Beigene, Daiichi Sankyo, Direct Biologics, Dragonboat, JW, Keymed, Lynk, Navidea, Novartis, Novavax, Nrx, Orion, Ribomic, Serum Institute of India, Takeda.